3Caligo MA, Cipollini G, Fiore L, et al. NM23 gene expression correlates with cell growth rate and S-phase [J]. Int J Cancer, 1995, 60(6) :837-842.
4Vessey CJ, Wilding J, Folarin N, et al. Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma [ J ]. J Pathol, 1995,176 ( 2 ) : 151-159.
5Enblad P, Adami HO, Bergstrom R, et al. Improved survival of patients with cancers of the colon and rectume[J]. J Natl Cancer Inst,1988, 80: 586 - 591.
6Naor D, Sionov RV, Ish - Shalom D. CD44: structure, function and association with the malignant process[J]. Adv Cancer Res, 1997, 71:241.
7Iida N, Bourguign on LY. New CD44 splice variants associated with human breast cancers[J]. J Cell Physiol, 1995, 162:127 - 133.
8Lokeshwar VB, Bourguignon LY. The lymphoma transmembrane glycoprotein GP85 (CD44) is a novel guanine nucleotide - binding protein with regulates GP85(CD44) - ankyrin interaction[J]. J Biol Chem,1992, 267: 22073 - 22078.
9Herrlich P, Zoller M, Pals ST, et al. CD44 splice variants: metastases meet lymphocytes[J]. Immunol Today, 1993,14: 395 - 399.
10Wielenga V J, Heider KH, Offerhaus GJ, et al. Expression of CD44variant proteins in human colorectal cancer is related to tumor progression[ J]. Cancer Res, 1993, 53:4754 - 4756.
